Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $6.94 billion. The enterprise value is $6.94 billion.
| Market Cap | 6.94B |
| Enterprise Value | 6.94B |
Important Dates
The next confirmed earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 135.32 million shares outstanding. The number of shares has increased by 11.68% in one year.
| Shares Outstanding | 135.32M |
| Shares Change (YoY) | +11.68% |
| Shares Change (QoQ) | +11.37% |
| Owned by Insiders (%) | 0.79% |
| Owned by Institutions (%) | 97.35% |
| Float | 111.92M |
Valuation Ratios
The trailing PE ratio is 47.92 and the forward PE ratio is 18.66. Globus Medical's PEG ratio is 1.75.
| PE Ratio | 47.92 |
| Forward PE | 18.66 |
| PS Ratio | 4.42 |
| Forward PS | 2.76 |
| PB Ratio | 1.74 |
| P/FCF Ratio | 41.99 |
| PEG Ratio | 1.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.93, with an EV/FCF ratio of 42.01.
| EV / Earnings | 56.48 |
| EV / Sales | 4.42 |
| EV / EBITDA | 23.93 |
| EV / EBIT | 47.78 |
| EV / FCF | 42.01 |
Financial Position
The company has a current ratio of 4.88, with a Debt / Equity ratio of 0.13.
| Current Ratio | 4.88 |
| Quick Ratio | 2.60 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 1.79 |
| Debt / FCF | 3.15 |
| Interest Coverage | -7.22 |
Financial Efficiency
Return on equity (ROE) is 4.10% and return on invested capital (ROIC) is 2.19%.
| Return on Equity (ROE) | 4.10% |
| Return on Assets (ROA) | 3.30% |
| Return on Capital (ROIC) | 2.19% |
| Revenue Per Employee | $313,695 |
| Profits Per Employee | $24,575 |
| Employee Count | 5,000 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 0.96 |
Taxes
In the past 12 months, Globus Medical has paid $42.52 million in taxes.
| Income Tax | 42.52M |
| Effective Tax Rate | 25.71% |
Stock Price Statistics
The stock price has decreased by -11.74% in the last 52 weeks. The beta is 1.10, so Globus Medical's price volatility has been higher than the market average.
| Beta (1Y) | 1.10 |
| 52-Week Price Change | -11.74% |
| 50-Day Moving Average | 53.09 |
| 200-Day Moving Average | 52.63 |
| Relative Strength Index (RSI) | 44.30 |
| Average Volume (30 Days) | 1,050,159 |
Short Selling Information
The latest short interest is 7.76 million, so 5.74% of the outstanding shares have been sold short.
| Short Interest | 7.76M |
| Short Previous Month | 5.73M |
| Short % of Shares Out | 5.74% |
| Short % of Float | 6.94% |
| Short Ratio (days to cover) | 7.36 |
Income Statement
In the last 12 months, Globus Medical had revenue of $1.57 billion and earned $122.87 million in profits. Earnings per share was $1.07.
| Revenue | 1.57B |
| Gross Profit | 1.02B |
| Operating Income | 133.14M |
| Pretax Income | 165.39M |
| Net Income | 122.87M |
| EBITDA | 290.00M |
| EBIT | 145.26M |
| Earnings Per Share (EPS) | $1.07 |
Balance Sheet
The company has $517.79 million in cash and $520.40 million in debt, giving a net cash position of -$2.62 million or -$0.02 per share.
| Cash & Cash Equivalents | 517.79M |
| Total Debt | 520.40M |
| Net Cash | -2.62M |
| Net Cash Per Share | -$0.02 |
| Equity / Book Value | 4.00B |
| Book Value Per Share | 29.54 |
| Working Capital | 1.52B |
Cash Flow
In the last 12 months, operating cash flow was $243.50 million and capital expenditures -$78.27 million, giving a free cash flow of $165.23 million.
| Operating Cash Flow | 243.50M |
| Capital Expenditures | -78.27M |
| Free Cash Flow | 165.23M |
| FCF Per Share | $1.46 |
Margins
Gross margin is 65.05%, with operating and profit margins of 8.49% and 7.83%.
| Gross Margin | 65.05% |
| Operating Margin | 8.49% |
| Pretax Margin | 10.54% |
| Profit Margin | 7.83% |
| EBITDA Margin | 18.49% |
| EBIT Margin | 9.26% |
| FCF Margin | 10.53% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.68% |
| Shareholder Yield | -11.68% |
| Earnings Yield | 1.77% |
| FCF Yield | 2.38% |
Analyst Forecast
The average price target for Globus Medical is $66.33, which is 29.37% higher than the current price. The consensus rating is "Buy".
| Price Target | $66.33 |
| Price Target Difference | 29.37% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 17.47% |
| EPS Growth Forecast (5Y) | 36.55% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 4.9 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.9 |
| Piotroski F-Score | 4 |